Clinical Trials Browser

Uterine Cervical Neoplasms × SHR-1701 × Clear all

NCT05179239 2025-04-15

A Study of SHR-1701 Plus Platinum-containing Chemotherapy With or Without BP102 (Bevacizumab) as First-line Treatment in Cervical Cancer

Phase 3 Terminated

Uterine Cervical Neoplasms